Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761)

Ophthalmology. 2017 Mar;124(3):e31-e32. doi: 10.1016/j.ophtha.2016.05.054.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors
  • Bevacizumab
  • Humans
  • Macular Degeneration
  • Ranibizumab
  • Vascular Endothelial Growth Factor A*
  • Wet Macular Degeneration*

Substances

  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Ranibizumab